PHARMACEUTICAL NEWS

Teva and Merck Agree on Generic Temodar Launch - ABC News
Date: Mar 17 2010  |  Feed Source: Google


Emerging economies represent \'pharmerging\' pharma markets - Packaging World
Date: Mar 17 2010  |  Feed Source: Google


Emerging economies represent \'pharmerging\' pharma markets - Packaging World
Date: Mar 17 2010  |  Feed Source: Google


Augme Expands Mobile Health Division Capitalizing on Major Growth Trend in ... - MarketWatch (press release)
Date: Mar 17 2010  |  Feed Source: Google


Augme Expands Mobile Health Division Capitalizing on Major Growth Trend in Pharmaceutical Mobile Marketing (Business Wire via Yahoo! Finance)
Date: Mar 17 2010  |  Feed Source: Yahoo!

NEW YORK----Augme Technologies, Inc. , a leading technology and services leader in interactive media marketing platforms, announced today that the company is expanding Augme Mobile Health as part of its business development strategy to capitalize on major growth trends in pharmaceutical mobile marketing and advertising.

The Top 10 Eastern European Pharmaceutical Companies: Growth Strategies, Performance And SWOT Analyses - New Market ... (OfficialWire)
Date: Mar 17 2010  |  Feed Source: Yahoo!

The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends.

King Pharmaceuticals Announces US Department of Justice Settlement - CNNMoney.com (press release)
Date: Mar 17 2010  |  Feed Source: Google


Teva Provides Update on Generic Temodar(R) - MarketWatch (press release)
Date: Mar 17 2010  |  Feed Source: Google


Acucela, Otsuka Pharmaceutical granted FDA Fast Track designation for ACU-4429 in treatment of dry AMD (News-Medical-Net)
Date: Mar 17 2010  |  Feed Source: Yahoo!

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).

Tekmira Pharmaceuticals Provides Corporate Update and Reports 2009 Audited Results - MarketWatch (press release)
Date: Mar 17 2010  |  Feed Source: Google


 1 2 3 >  Last ›

Browse by Category


Browse by Condition